Sesamolinol



Compound IDCDAMM00158
Common nameSesamolinol
IUPAC name4-[[(3S,3aR,6R,6aR)-3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]oxy]-2-methoxyphenol
Molecular formulaC20H20O7

Experimental data

Retention time52.02
Adduct[M+H]+
Actual mz373.129
Theoretical mz373.128
Error1.68
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.842

Identifiers and class information

Inchi keyOJVGWDJIYBTWDS-UHFFFAOYNA-N
SmilesCOC1=C(C=CC(=C1)OC2C3COC(C3CO2)C4=CC5=C(C=C4)OCO5)O
SuperclassBenzenoids
ClassPhenols

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)4
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)372.374
Computed dipole moment(dipole)2.477
Total solvent accessible surface area (SASA)597.068
Hydrophobic component of SASA (FOSA)312.915
Hydrophilic component of SASA (FISA)54.044
Pie component of the SASA (PISA)230.109
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1068.79
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)7.15
Free energy of solvation of dipole (dip^2/V)0.0057404
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0119752
Globularity descriptor (glob)0.846715
Predicted polarizability in cubic angstroms (QPpolrz)36.248
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.383
Predicted octanol/gas partition coefficient (QPlogPoct)16.921
Predicted water/gas partition coefficient (QPlogPw)10.714
Predicted octanol/water partition coefficient (QPlogPo/w)2.913
Predicted aqueous solubility (QPlogS)-3.932
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.855
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.11
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)3043.67
Predicted brain/blood partition coefficient (QPlogBB)-0.18
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1647.58
Predicted skin permeability, log Kp (QPlogKp)-1.321
PM3 calculated ionization potential (IP(ev))8.542
PM3 calculated electron affinity (EA(eV))0.083
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)-0.027
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)72.539
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P25101EDNRAEndothelin receptor ET-AT23499SEA
P24530EDNRBEndothelin receptor ET-BT92828SEA
P14679TYRTyrosinaseT97035SEA
P10636MAPTMicrotubule-associated protein tauT45593SEA
P51843NR0B1Orphan nuclear receptor DAX-1T23191SEA
Q8N183NDUFAF2HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2T01453SEA
Q9P0J0NDUFA13Mitochondrial complex IT82391SEA
Q9Y6M9NDUFB9HUMAN NADH:ubiquinone oxidoreductase subunit B9T01465SEA
Q8N183NDUFAF2HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2T01453SEA
P03897MT-ND3NADH dehydrogenaseT77195SEA
Q02880TOP2BDNA topoisomerase II betaT85733SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T23499DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P25101EDNRA
T23499DI0356Pulmonary hypertension[ICD-11: BB01]P25101EDNRA
T23499DI0425Urinary system clinical symptom[ICD-11: MF8Y]P25101EDNRA
T92828DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P24530EDNRB
T92828DI0356Pulmonary hypertension[ICD-11: BB01]P24530EDNRB
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T45593DI0012Acute myeloid leukaemia[ICD-11: 2A60]P10636MAPT
T45593DI0025Alzheimer disease[ICD-11: 8A20]P10636MAPT
T45593DI0265Mild neurocognitive disorder[ICD-11: 6D71]P10636MAPT
T82391DI0069Cardiomyopathy[ICD-11: BC43]Q9P0J0NDUFA13
T77195DI0331Parkinsonism[ICD-11: 8A00]P03897MT-ND3
T85733DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q02880TOP2B
T85733DI0076Chemoprotection[ICD-11: N.A.]Q02880TOP2B

Copyright © 2025